Results: 1-16 |
Results: 16

Authors: Komata, T Koga, S Hirohata, S Takakura, M Germano, IM Inoue, M Kyo, S Kondo, S Kondo, Y
Citation: T. Komata et al., A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptasegene promoter, INT J ONCOL, 19(5), 2001, pp. 1015-1020

Authors: Kondo, Y Komata, T Kondo, S
Citation: Y. Kondo et al., Combination therapy of 2-5A antisense against telomerase RNA and cisplatinfor malignant gliomas, INT J ONCOL, 18(6), 2001, pp. 1287-1292

Authors: Koga, S Kondo, Y Komata, T Kondo, S
Citation: S. Koga et al., Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisensetelomerase RNA, GENE THER, 8(8), 2001, pp. 654-658

Authors: Koga, S Hirohata, S Kondo, Y Komata, T Takakura, M Inoue, M Kyo, S Kondo, S
Citation: S. Koga et al., FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo, ANTICANC R, 21(3B), 2001, pp. 1937-1943

Authors: Nomura, M Wang, YL Yamazaki, Y Hirano, K Kato, Y Ishikawa, T Komata, T Hiyama, T
Citation: M. Nomura et al., Development of a traveling wave resonant ring of the JNC high-power, high-duty electron linac, NUCL INST A, 463(1-2), 2001, pp. 42-49

Authors: Campbell, SB Komata, T Kelso, A
Citation: Sb. Campbell et al., CD4 ligation promotes the IL-4-independent development of IL-4-producing clones from naive CD4(+) T cells, J IMMUNOL, 167(10), 2001, pp. 5610-5619

Authors: Komata, T Kondo, Y Kanzawa, T Hirohata, S Koga, S Sumiyoshi, H Srinivasula, SM Barna, BP Germano, IM Takakura, M Inoue, M Alnemri, ES Shay, JW Kyo, S Kondo, S
Citation: T. Komata et al., Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter, CANCER RES, 61(15), 2001, pp. 5796-5802

Authors: Ohashi, J Yamamoto, S Tsuchiya, N Hatta, Y Komata, T Matsushita, M Tokunaga, K
Citation: J. Ohashi et al., Comparison of statistical power between 2x2 allele frequency and allele positivity tables in case-control studies of complex disease genes, ANN HUM GEN, 65, 2001, pp. 197-206

Authors: Koga, S Hirohata, S Kondo, Y Komata, T Takakura, M Inoue, M Kyo, S Kondo, S
Citation: S. Koga et al., A novel telomerase-specific gene therapy: Gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter, HUM GENE TH, 11(10), 2000, pp. 1397-1406

Authors: Komata, T Kondo, Y Koga, S Ko, SC Chung, LWK Kondo, S
Citation: T. Komata et al., Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53, GENE THER, 7(24), 2000, pp. 2071-2079

Authors: Kondo, Y Koga, S Komata, T Kondo, S
Citation: Y. Kondo et al., Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component, ONCOGENE, 19(18), 2000, pp. 2205-2211

Authors: Campbell, SB Komata, T Kelso, A
Citation: Sb. Campbell et al., Differential effects of CD4 and CD8 engagement on the development of cytokine profiles of murine CD4(+) and CD8(+) T lymphocytes, IMMUNOLOGY, 99(3), 2000, pp. 394-401

Authors: Mukai, S Kondo, Y Koga, S Komata, T Barna, BP Kondo, S
Citation: S. Mukai et al., 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas', CANCER RES, 60(16), 2000, pp. 4461-4467

Authors: Shibue, T Tsuchiya, N Komata, T Matsushita, M Shiota, M Ohashi, J Wakui, M Matsuta, K Tokunaga, K
Citation: T. Shibue et al., Tumor necrosis factor alpha 5 '-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis, ARTH RHEUM, 43(4), 2000, pp. 753-757

Authors: Matsushita, M Tsuchiya, N Shiota, M Komata, T Matsuta, K Zama, K Oka, T Juji, T Yamane, A Tokunaga, K
Citation: M. Matsushita et al., Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method, TISSUE ANTI, 54(6), 1999, pp. 578-584

Authors: Komata, T Tsuchiya, N Matsushita, M Hagiwara, K Tokunaga, K
Citation: T. Komata et al., Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus, TISSUE ANTI, 53(6), 1999, pp. 527-533
Risultati: 1-16 |